HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.

Abstract
Acolbifene (ACOL) is a fourth-generation selective estrogen receptor modulator (SERM) that has strong and pure antiestrogenic properties toward estrogen-sensitive cancers, but improves energy and lipid metabolism in an estrogen-like fashion in rodent models. The aim of this study was to determine the potency of ACOL to reduce cholesterolemia in a dietary model of hypercholesterolemia and to establish its mechanisms of action. Intact and ovariectomized (OVX) female rats were treated for 3 weeks with ACOL, and serum cholesterol and liver determinants of cholesterol metabolism were assessed. Acolbifene prevented both diet- and ovariectomy-induced weight gain and completely prevented diet-induced hypercholesterolemia. Relative to a reference chow diet, the high-cholesterol diet decreased the high-density lipoprotein (HDL) cholesterol fraction, which remained unaffected by ACOL, indicating that in hypercholesterolemic conditions, ACOL modulated only the non-HDL fraction. No impact of ACOL on determinants of liver cholesterol synthesis was observed. In contrast, ACOL increased hepatic low-density lipoprotein receptor protein in both intact and OVX rats, which was negatively correlated with serum total and non-HDL cholesterol (r=-0.59, P<.0001), suggesting a contribution of receptor-mediated hepatic uptake of cholesterol-rich lipoproteins to the hypocholesterolemic effect of ACOL. These findings establish that ACOL retains its powerful cholesterol-lowering action in diet-induced hypercholesterolemia and suggest that the SERM acts in such conditions through favoring hepatic low-density lipoprotein receptor-mediated uptake of cholesterol transported by non-HDL lipoprotein fractions.
AuthorsChristian Lemieux, Yves Gélinas, Josée Lalonde, Fernand Labrie, Denis Richard, Yves Deshaies
JournalMetabolism: clinical and experimental (Metabolism) Vol. 55 Issue 5 Pg. 605-13 (May 2006) ISSN: 0026-0495 [Print] United States
PMID16631436 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP-Binding Cassette Transporters
  • Blood Glucose
  • Cholesterol, Dietary
  • Piperidines
  • RNA, Messenger
  • Receptors, LDL
  • Selective Estrogen Receptor Modulators
  • Sterol Regulatory Element Binding Proteins
  • ritetronium
  • Hydroxymethylglutaryl CoA Reductases
Topics
  • ATP-Binding Cassette Transporters (genetics, metabolism)
  • Animals
  • Blood Glucose (metabolism)
  • Cholesterol, Dietary (metabolism)
  • Female
  • Hydroxymethylglutaryl CoA Reductases (metabolism)
  • Hypercholesterolemia (drug therapy, metabolism)
  • Liver (metabolism)
  • Ovariectomy
  • Piperidines (pharmacology)
  • RNA, Messenger (chemistry, genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, LDL (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Selective Estrogen Receptor Modulators (pharmacology)
  • Statistics, Nonparametric
  • Sterol Regulatory Element Binding Proteins (genetics, metabolism)
  • Weight Gain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: